Consulting & Strategy
Science-based advisory for governments, international institutions, pharmaceutical partners, and foundations — delivered at the standard of the journals we publish in.
Engagement model
Available as business-to-business and client-to-consultant engagements. All advisory work is conducted independently and in full compliance with applicable institutional policies.
We accept a limited number of engagements per year to ensure depth and quality of service. Our advisory draws directly on a peer-reviewed evidence base spanning 37 countries and 156 million adults — as well as 12+ years of direct engagement with WHO, health ministries, and international partners across 194 Member States.
Our services
Strategic advisory for ministries of health and national noncommunicable disease programmes on the design, scale-up, and evaluation of hypertension and diabetes control initiatives — grounded in WHO frameworks and implementation science.
Advisory board participation, market access strategy, clinical evidence reviews, and regulatory landscape analysis for cardiovascular and cardiometabolic portfolios.
Bespoke burden-of-disease analyses, Bayesian spatiotemporal modelling, secondary data analysis, and econometric evaluations — drawing on expertise from multi-country STEPS surveys covering 37 countries and 156 million adults.
Protocol development, grant proposal writing, statistical analysis plans, and senior methodological oversight for research teams — backed by 38+ publications in JACC, JAMA Cardiology, BMJ Global Health, The Lancet, and eClinicalMedicine.
Technical consulting and programme support across the francophone–anglophone divide. Native French, fluent English — enabling seamless coordination with Gavi, the Global Fund, Resolve to Save Lives, Bloomberg Philanthropies, and bilateral donors worldwide.
Keynote lectures, panel moderation, and executive education sessions on cardiovascular disease prevention, noncommunicable disease policy, implementation science, and the future of primary health care in low-resource settings. Available in English and French.
I support health institutions, research teams, ministries, NGOs, and programme leaders in using artificial intelligence safely and effectively for public health and cardiovascular priorities. My services include AI strategy development, use-case identification, tool appraisal, governance frameworks, ethical and regulatory guidance, data quality and bias assessment, prompt engineering, workflow design, capacity building, and support for responsible AI deployment. I help teams move from interest in AI to practical, evidence-informed solutions that improve decision-making, strengthen prevention programmes, support cardiovascular care, and deliver measurable public health impact.
Our advisory is not theoretical. It is built on the same evidence base that has informed previous technical support — peer-reviewed, multi-country, and grounded in the realities of health systems around the world, particularly in low- and middle-income countries.
We bring together epidemiological and scientific rigour, policy expertise, AI expertise, and more than 20 years of direct implementation experience across 194 countries — a combination that is genuinely rare in the global health advisory space.
Every engagement is led by a pool of highly experienced global experts.
We invite enquiries from governments, international institutions, academic partners, foundations, and pharmaceutical companies aligned with our mission.
Send an enquiry